Menu Search
Equities

Infant Bacterial Therapeutics AB

IBT B:STO

Infant Bacterial Therapeutics AB

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (SEK)38.20
  • Today's Change0.600 / 1.60%
  • Shares traded20.66k
  • 1 Year change-57.74%
  • Beta0.7649
Data delayed at least 15 minutes, as of Nov 22 2024 17:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in SEKView more

In 2023, Infant Bacterial Therapeutics AB did not generate a significant amount of cash. Cash Flow from Financing totalled 96.52m or -- of revenues. In addition the company used 101.22m for operations while cash used for investing totalled .
Cash flow per share-10.62
Price/Cash flow per share--
Book value per share15.15
Tangible book value per share14.47
More ▼

Balance sheet in SEKView more

Infant Bacterial Therapeutics AB appears to have little financial risk as the company holds a substantial amount of cash on its books with little or no debt.
Current ratio6.52
Quick ratio--
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.